These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35653590)

  • 1. Anticoagulation in hospitalized patients with COVID-19.
    Baumann Kreuziger L; Sholzberg M; Cushman M
    Blood; 2022 Aug; 140(8):809-814. PubMed ID: 35653590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
    Ahmed HY; Papali A; Haile T; Shrestha GS; Schultz MJ; Lundeg G; Akrami KM;
    Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):99-109. PubMed ID: 33432908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years.
    Rizk JG; Gupta A; Lazo JG; Sardar P; Henry BM; Lavie CJ; Effron MB
    Semin Thromb Hemost; 2023 Feb; 49(1):62-72. PubMed ID: 35468641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation.
    Trigonis RA; Holt DB; Yuan R; Siddiqui AA; Craft MK; Khan BA; Kapoor R; Rahman O
    Crit Care Med; 2020 Sep; 48(9):e805-e808. PubMed ID: 32618699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
    Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
    Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    Davidson BL; Levi MM
    JAMA; 2023 Aug; 330(5):471-472. PubMed ID: 37526726
    [No Abstract]   [Full Text] [Related]  

  • 9. Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia.
    Go RC; Nyirenda T; Bojarian M; Hosseini DK; Rahim M; Kim K; Rose KM
    BMC Pulm Med; 2022 Jan; 22(1):6. PubMed ID: 34986821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19.
    Stone GW; Farkouh ME; Lala A; Tinuoye E; Dressler O; Moreno PR; Palacios IF; Goodman SG; Esper RB; Abizaid A; Varade D; Betancur JF; Ricalde A; Payro G; Castellano JM; Hung IFN; Nadkarni GN; Giustino G; Godoy LC; Feinman J; Camaj A; Bienstock SW; Furtado RHM; Granada C; Bustamante J; Peyra C; Contreras J; Owen R; Bhatt DL; Pocock SJ; Fuster V;
    J Am Coll Cardiol; 2023 May; 81(18):1747-1762. PubMed ID: 36889611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week.
    Farkouh ME; Stone GW; Lala A; Bagiella E; Moreno PR; Nadkarni GN; Ben-Yehuda O; Granada JF; Dressler O; Tinuoye EO; Granada C; Bustamante J; Peyra C; Godoy LC; Palacios IF; Fuster V
    J Am Coll Cardiol; 2022 Mar; 79(9):917-928. PubMed ID: 35241226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of venous thromboembolism in COVID-19: A clinical perspective.
    Ozsu S; Gunay E; Konstantinides SV
    Clin Respir J; 2021 May; 15(5):506-512. PubMed ID: 33484090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU.
    Pluta J; Cieniewicz A; Trzebicki J
    Anaesthesiol Intensive Ther; 2021; 53(2):153-161. PubMed ID: 34006056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.
    Dimakakos E; Gomatou G; Catalano M; Olinic DM; Spyropoulos AC; Falanga A; Maraveyas A; Liew A; Schulman S; Belch J; Gerotziafas G; Marschang P; Cosmi B; Spaak J; Syrigos K;
    Anticancer Res; 2022 Jul; 42(7):3261-3274. PubMed ID: 35790272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of venous thromboembolism in hospitalized patients with COVID-19.
    Spyropoulos AC
    Blood Adv; 2020 Aug; 4(16):4028. PubMed ID: 32841342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Thrombotic Complications and Therapeutic Strategies.
    Fanaroff AC; Lopes RD
    Annu Rev Med; 2023 Jan; 74():15-30. PubMed ID: 36130046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
    Ortega-Paz L; Galli M; Capodanno D; Franchi F; Rollini F; Bikdeli B; Mehran R; Montalescot G; Gibson CM; Lopes RD; Andreotti F; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):677-686. PubMed ID: 34519777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between pre-admission anticoagulation and in-hospital death, venous thromboembolism, and major bleeding among hospitalized COVID-19 patients in Japan.
    Adomi M; Kuno T; Komiyama J; Taniguchi Y; Abe T; Miyawaki A; Imai S; Morita K; Saito M; Ohbe H; Kamio T; Tamiya N; Iwagami M
    Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):680-688. PubMed ID: 35324035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The standard of care is standard for a reason: Commentary on "Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients: A systematic review and Meta-analysis of randomized clinical trials".
    Milano V; Hurt J; Nielsen ND
    J Crit Care; 2023 Oct; 77():154345. PubMed ID: 37244208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.